Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 170

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Prognostic markers of radiographic progression in early rheumatoid arthritis

Goronzy, Jörg J., Matteson, Eric L., Fulbright, James W., Warrington, Kenneth J., Chang‐Miller, April, Hunder, Gene G., Mason, Thomas G., Nelson, Audrey M., Valente, Robert M., Crowson, Cynthia S., Erlich, Henry A., Reynolds, Rebecca L., Swee, Ronald G., O'Fallon, W. Michael, Weyand, Cornelia M. · 2004 · Arthritis & Rheumatism

Abstract

Objective: To identify prognostic markers that are predictive of progressive erosive disease in patients with early rheumatoid arthritis (RA). Methods: The study involved an inception cohort of 111 consecutive patients with RA and a disease duration of <1 year. Patients were treated according to an algorithm designed to avoid overtreatment of mild disease and to accelerate treatment in patients who had continuous disease activity. Patients were evaluated for the presence of clinical and laboratory disease activity markers. We determined the frequency of CD4+,CD28 null T cells by flow cytometry, HLA–DRB1 gene polymorphisms by polymerase chain reaction (PCR)/sequencing, and 26 single‐nucleotide polymorphisms in 19 candidate genes by multiplex PCR and hybridization to an immobilized probe array. Data were analyzed using proportional odds models to identify prognostic markers predictive of erosive progression over 2 years on serial hand/wrist radiographs. Results: After 2 years, disease activity in 52% of the cohort was controlled by treatment with hydroxychloroquine and nonsteroidal agents. Forty‐eight percent of the patients did not develop erosions. Older age, presence of erosions at baseline, presence of rheumatoid factor, rheumatoid factor titer, and HLA–DRB1*04 alleles, particularly homozygosity for HLA–DRB1*04, were univariate predictors of radiographic progression. Promising novel markers were the frequency of CD4+,CD28 null T cells as an immunosenescence indicator, and a polymorphism in the uteroglobin gene. Conclusion: Clinical disease activity in patients with early RA can frequently be controlled with nonaggressive treatment, but this is not always sufficient to prevent new erosions. Rheumatoid factor titer, HLA–DRB1 polymorphisms, age, and immunosenescence markers are predictors of poor radiographic outcome. A polymorphism in the uteroglobin gene may identify patients who have a low risk of erosive disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.11445

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 170

Metadata

Authors
Goronzy, J. J., Matteson, E. L., Fulbright, J. W., Warrington, K. J., Chang‐Miller, A., Hunder, G. G., Mason, T. G., Nelson, A. M., Valente, R. M., Crowson, C. S., Erlich, H. A., Reynolds, R. L., Swee, R. G., O'Fallon, W. M., & Weyand, C. M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2004-01
Volume
50
Issue
1
Pages
43-54
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W1980455666
Cited by
170
References
2
FWCI
9.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.